Elanco Animal Health Incorporated Common Stock vs Immunovant Inc. Common Stock — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.62 (market cap $11.17B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: Elanco Animal Health Incorporated Common Stock is the larger of the two by market cap, and Elanco Animal Health Incorporated Common Stock is more actively traded (4,196,242 versus 1,131,364). Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| ELAN | IMVT | |
|---|---|---|
Market Cap | $11.17B | $6.62B |
Volume | 4,196,242 | 1,131,364 |
Sector | Health | Health |
52-Week High | $26.84 | $44.96 |
52-Week Low | $19.76 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.56B | $5.72B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →